In situ radiotherapy with 111In-pentetreotide: State of the art and perspectives

Quarterly Journal of Nuclear Medicine

Volumn 44, Issue 1, 2000, Pages 88-95

  McCarthy, K E ^a   Woltering, E A ^a   Anthony, L B ^a  

^a Department of Radiology ^*  (United States)

Author keywords

Auger; Cytotoxicity; Electron; Indium radioisotopes; Neuroendocrine tumors radiotherapy; Radiotherapy; Receptors, somatostatin; Somatostatin; Targeted therapy

Indexed keywords

INDIUM 111; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; WARFARIN; DRUG DERIVATIVE; INDIUM; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN;

ACUTE KIDNEY TUBULE NECROSIS; AUGER ELECTRON SPECTROSCOPY; CARCINOID; CLINICAL TRIAL; DOSE RESPONSE; HEMATOLOGIC DISEASE; HUMAN; LIVER TOXICITY; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL CARCINOMA; RADIOISOTOPE DISTRIBUTION; REVIEW; RADIATION DOSE;

HUMANS; INDIUM RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; SOMATOSTATIN;

EID: 0033624196     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)